Risks of Placental Chorioangioma in Pregnancy
Placental chorioangioma, particularly when large (>4 cm), poses substantial risks to both mother and fetus, with approximately one-third of large chorioangiomas causing severe complications requiring intervention or resulting in perinatal loss.
Fetal Risks
The fetus bears the greatest burden of complications from chorioangioma, especially with tumors exceeding 4 cm:
High-Risk Complications
- Fetal demise and intrauterine death - Risk increases nearly 10-fold (RR = 9.93) 1
- Hydrops fetalis - Results from high-output cardiac failure due to arteriovenous shunting through the tumor 2
- Severe fetal anemia and thrombocytopenia - Requiring neonatal blood product transfusion 3
- Fetal heart failure - From increased cardiac demand through tumor shunting 4
Moderate-Risk Complications
- Preterm birth - Risk increases 2.5-fold (RR = 2.45), with mean delivery around 33-34 weeks 1, 3
- Fetal growth restriction - Common finding requiring serial monitoring 4
- Polyhydramnios - Risk increases 10-fold (RR = 9.98), occurring in significant proportion of cases 1
- Fetal distress - Necessitating emergency delivery 3, 4
Mechanism of Fetal Complications
The pathophysiology centers on arteriovenous shunting through the highly vascular tumor, which diverts blood flow away from the fetus, leading to:
- High-output cardiac state
- Fetal anemia from sequestration
- Compromised placental perfusion
- Progressive cardiac decompensation
Maternal Risks
Maternal complications are less frequent but clinically significant:
- Postpartum hemorrhage/uterine atony - Documented in case reports requiring aggressive uterotonic management 3
- Preeclampsia - Risk increases 3.6-fold when controlling for preterm birth (RR = 3.6) 1
- Emergency cesarean delivery - Risk increases 1.6-fold (RR = 1.62) 1
- Preterm labor - Often spontaneous and difficult to arrest 3
Risk Stratification by Tumor Characteristics
Three independent factors determine complication risk:
1. Tumor Size (Most Critical)
- Small (<4 cm): Usually asymptomatic, discovered incidentally, minimal risk 5
- Large (≥4 cm): One-third develop severe complications, one-fifth result in perinatal loss 5
2. Tumor Vascularity
- High vascularity on Doppler ultrasound correlates with increased shunting and fetal compromise 4
3. Tumor Location
Clinical Management Implications
Close antenatal surveillance is mandatory for all diagnosed cases:
- Serial ultrasound monitoring - Every 2-4 weeks to assess tumor growth
- Doppler flowmetry - To evaluate shunting and fetal cardiac status 2
- Amniotic fluid assessment - To detect polyhydramnios early 2
- Fetal echocardiography - To identify early cardiac decompensation 4
- Multidisciplinary planning - Involving maternal-fetal medicine, neonatology, and anesthesia 3
Critical Pitfalls to Avoid
- Underestimating small tumors: While most are benign, any chorioangioma warrants increased surveillance
- Delayed recognition of fetal heart failure: This is the most ominous complication requiring immediate delivery
- Inadequate preparation for delivery: Have blood products available and senior staff present given hemorrhage risk 3
- Missing polyhydramnios: This often precedes other complications and signals tumor activity
Prognosis
For surviving neonates, long-term developmental outcomes are generally excellent 5, 1. However, the perinatal period carries substantial risk, with approximately 20% of fetuses with large chorioangiomas experiencing perinatal loss 5. When complications are mild or early delivery is feasible, prognosis improves dramatically 1.
The incidence of placental chorioangioma is approximately 0.04-0.17% of all pregnancies, with large tumors representing only 0.04% 5.